Consun Pharmaceutical Posts Strong Mid-Year Gains
Company Announcements

Consun Pharmaceutical Posts Strong Mid-Year Gains

Consun Pharmaceutical Group Ltd. (HK:1681) has released an update.

Consun Pharmaceutical Group Ltd. reports a solid financial performance in the first half of 2024, with a revenue increase of 13.3% and a profit jump of 14.9% compared to the same period in 2023. The company also saw a rise in both basic and diluted earnings per share by over 12%, alongside declaring an interim dividend of HKD0.3 per share.

For further insights into HK:1681 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskConsun Pharmaceutical Group Aims for Paperless Compliance
TipRanks HongKong Auto-Generated NewsdeskConsun Pharma Declares Mid-Year Dividend
TipRanks HongKong Auto-Generated NewsdeskConsun Pharma Reschedules Dividend Record Date
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App